Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideko Yamauchi

Showing results (101-110 of 130) with videos related to

Pageof 13
Sort By:
Pathology International|January 10, 2015
The significance of combined CK5/6 and p63 immunohistochemistry in predicting the risks of subsequent carcinoma development in intraductal papilloma of the breastYang Yang, Koyu Suzuki, Eriko Abe, et al.
Breast Cancer Research and Treatment|April 15, 2014
Randomized phase II study of weekly paclitaxel with and without carboplatin followed by cyclophosphamide/epirubicin/5-fluorouracil as neoadjuvant chemotherapy for stage II/IIIA breast cancer without HER2 overexpressionMasashi Ando, Hideko Yamauchi, Kenjiro Aogi, et al.
Pathology International|March 18, 2014
Clinicopathological significance of 'atypical ductal proliferation' in core needle biopsy of the breastEriko Abe, Koyu Suzuki, Naoki Hayashi, et al.
The Annals of Thoracic Surgery|July 5, 2003
Benefits of off-pump bypass on neurologic and clinical morbidity: a prospective randomized trialJeffrey D Lee, Shay J Lee, William T Tsushima, et al.
Breast Cancer (Tokyo, Japan)|November 20, 2013
Prevalence and differentiation of hereditary breast and ovarian cancers in JapanSeigo Nakamura, Masato Takahashi, Mitsuhiro Tozaki, et al.
Communications Biology|December 16, 2021
MicroSEC filters sequence errors for formalin-fixed and paraffin-embedded samplesMasachika Ikegami, Shinji Kohsaka, Takeshi Hirose, et al.
Journal of Surgical Oncology|September 9, 2015
A model to predict upstaging to invasive carcinoma in patients preoperatively diagnosed with ductal carcinoma in situ of the breastTakafumi Kondo, Naoki Hayashi, Sachiko Ohde, et al.
Annals of Surgical Oncology|October 6, 2020
Risk Factors for Ipsilateral Breast Tumor Recurrence in Triple-Negative or HER2-Positive Breast Cancer Patients Who Achieve a Pathologic Complete Response After Neoadjuvant ChemotherapyMakoto Ishitobi, Naoko Matsuda, Mizuho Tazo, et al.
Breast Cancer (Tokyo, Japan)|September 29, 2022
A prospective analysis of two studies that used the 5-mm interval slices and 5-mm margin-free method for ipsilateral breast tumor recurrence after breast-conserving surgery without radiotherapyShozo Ohsumi, Reiki Nishimura, Norikazu Masuda, et al.
The Oncologist|May 16, 2012
Inflammatory breast cancer: what we know and what we need to learnHideko Yamauchi, Wendy A Woodward, Vicente Valero, et al.
Pageof 13

Showing results (101-110 of 130) with videos related to

Sort By:
Pageof 13
Pathology International|January 10, 2015
The significance of combined CK5/6 and p63 immunohistochemistry in predicting the risks of subsequent carcinoma development in intraductal papilloma of the breastYang Yang, Koyu Suzuki, Eriko Abe, et al.
Breast Cancer Research and Treatment|April 15, 2014
Randomized phase II study of weekly paclitaxel with and without carboplatin followed by cyclophosphamide/epirubicin/5-fluorouracil as neoadjuvant chemotherapy for stage II/IIIA breast cancer without HER2 overexpressionMasashi Ando, Hideko Yamauchi, Kenjiro Aogi, et al.
Pathology International|March 18, 2014
Clinicopathological significance of 'atypical ductal proliferation' in core needle biopsy of the breastEriko Abe, Koyu Suzuki, Naoki Hayashi, et al.
The Annals of Thoracic Surgery|July 5, 2003
Benefits of off-pump bypass on neurologic and clinical morbidity: a prospective randomized trialJeffrey D Lee, Shay J Lee, William T Tsushima, et al.
Breast Cancer (Tokyo, Japan)|November 20, 2013
Prevalence and differentiation of hereditary breast and ovarian cancers in JapanSeigo Nakamura, Masato Takahashi, Mitsuhiro Tozaki, et al.
Communications Biology|December 16, 2021
MicroSEC filters sequence errors for formalin-fixed and paraffin-embedded samplesMasachika Ikegami, Shinji Kohsaka, Takeshi Hirose, et al.
Journal of Surgical Oncology|September 9, 2015
A model to predict upstaging to invasive carcinoma in patients preoperatively diagnosed with ductal carcinoma in situ of the breastTakafumi Kondo, Naoki Hayashi, Sachiko Ohde, et al.
Annals of Surgical Oncology|October 6, 2020
Risk Factors for Ipsilateral Breast Tumor Recurrence in Triple-Negative or HER2-Positive Breast Cancer Patients Who Achieve a Pathologic Complete Response After Neoadjuvant ChemotherapyMakoto Ishitobi, Naoko Matsuda, Mizuho Tazo, et al.
Breast Cancer (Tokyo, Japan)|September 29, 2022
A prospective analysis of two studies that used the 5-mm interval slices and 5-mm margin-free method for ipsilateral breast tumor recurrence after breast-conserving surgery without radiotherapyShozo Ohsumi, Reiki Nishimura, Norikazu Masuda, et al.
The Oncologist|May 16, 2012
Inflammatory breast cancer: what we know and what we need to learnHideko Yamauchi, Wendy A Woodward, Vicente Valero, et al.
Pageof 13